event header image
https://flaia-cms-assets.s3.amazonaws.com/20210331_DSC_03239_1_188018ffd3.JPG
Stephen Malloy
Founder & CEO @ PharmaRolly

Malloy is the founder and CEO of PharmaRolly Holdings B.V., which is comprised mainly of a small number of institutional and UHNW investors. Mr. Malloy has over 26 years of international management and investment experience. Mr. Malloy has founded, managed and held senior roles at various successful global companies. Mr. Malloy has worked with pension funds, consultants, ultra high net worth individuals, family offices and other institutions.

Past Speaking Events

  • PharmaRolly Investment Summit: Unlocking the European Cannabis Market hosted by PharmaRolly
    July 10, 2024
    11:00 AM - 12:00 PM
    Webcast
    View Details

    Join us for an exclusive virtual summit where PharmaRolly Holdings B.V., a leader in THC-dominant medical cannabis, will unveil unparalleled investment opportunities in the rapidly growing European cannabis market. This event is designed to provide you with key insights into PharmaRolly's strategic positioning, robust infrastructure, and experienced management team, all poised to deliver significant returns.

    Speakers: Stephen Malloy

  • Deep Dive Into the EU's Legal Cannabis Market hosted by PharmaRolly
    November 11, 2022
    12:45 PM - 13:45 PM
    Webcast
    View Details

    Steve Malloy, Founder & CEO of PharmaRolly based out of the Netherlands will discuss the state of cannabis in Europe. Steve will talk about import and export opportunities that he is seeing today. Most US investors do not realize the legal structure of cannabis in Europe. Steve will take us on a deep dive into the EU Cannabis Market and I will try my best to help you get the most out of your time. If you have any questions or would like an introduction to Steve, please send me an email at michael@flaia.org.

    Speakers: Stephen Malloy

About PHARMAROLLY

company logo

PharmaRolly, a Dutch company operating at the highest international standards, is the only operator to elevate fully organic living soil-grown craft cannabis to a commercialized, standardized, and purified end product at the most competitive prices in Europe – putting patient access to organic medicine first.